Clarkston Capital Partners LLC Purchases 7,164 Shares of Kenvue Inc. (NYSE:KVUE)

Clarkston Capital Partners LLC boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 0.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,368,958 shares of the company’s stock after purchasing an additional 7,164 shares during the quarter. Clarkston Capital Partners LLC’s holdings in Kenvue were worth $31,664,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. ING Groep NV lifted its holdings in shares of Kenvue by 23.6% during the 3rd quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock worth $82,727,000 after acquiring an additional 681,954 shares during the period. Lorne Steinberg Wealth Management Inc. lifted its position in shares of Kenvue by 59.0% during the second quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company’s stock worth $2,812,000 after purchasing an additional 57,375 shares in the last quarter. Kennon Green & Company LLC boosted its position in Kenvue by 140.7% in the 2nd quarter. Kennon Green & Company LLC now owns 159,106 shares of the company’s stock valued at $2,893,000 after buying an additional 93,008 shares during the last quarter. Czech National Bank boosted its holdings in Kenvue by 20.3% in the second quarter. Czech National Bank now owns 364,886 shares of the company’s stock valued at $6,634,000 after acquiring an additional 61,635 shares during the last quarter. Finally, Crestwood Advisors Group LLC grew its position in shares of Kenvue by 14.8% during the 2nd quarter. Crestwood Advisors Group LLC now owns 1,537,348 shares of the company’s stock worth $27,950,000 after buying an additional 198,607 shares during the period. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on KVUE shares. Piper Sandler upped their price target on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, September 23rd. Bank of America lifted their price target on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Jefferies Financial Group began coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price for the company. Royal Bank of Canada cut Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target for the company. in a research report on Tuesday, September 24th. Finally, JPMorgan Chase & Co. increased their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $22.64.

Kenvue Stock Performance

KVUE opened at $23.82 on Monday. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.13. The company has a market cap of $45.67 billion, a price-to-earnings ratio of 43.31, a PEG ratio of 2.16 and a beta of 1.36. The company’s fifty day moving average price is $22.77 and its two-hundred day moving average price is $20.70. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same period in the prior year, the firm posted $0.31 EPS. The firm’s quarterly revenue was down .4% compared to the same quarter last year. On average, analysts expect that Kenvue Inc. will post 1.07 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be given a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.44%. Kenvue’s dividend payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.